Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F63L9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,507
Award facts
- Contract value 100% obligated
- $1,506.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Emgality, a CGRP monoclonal antibody indicated for migraine prevention, represents one of the specialized pharmaceutical products AmerisourceBergen supplies through its comprehensive federal medical procurement vehicle.
This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal military healthcare supply chain. The company's extensive IDC with DLA Troop Support Medical enables it to supply a wide range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen's demonstrated capability to fulfill competitive federal procurements across varying order values and therapeutic domains has established the company as a primary vendor for military pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26F63L9?
SPE2DR26F63L9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F63L9 worth?
The government has obligated $1,507 on SPE2DR26F63L9.
Is contract SPE2DR26F63L9 an order under another contract?
Yes. SPE2DR26F63L9 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63L9 competed?
The extent of competition for SPE2DR26F63L9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award